IE00BF0H7608
IE00BF0H7608
L&G Pharma Breakthrough UCITS ETF
Loading chart...
Holdings & Portfolio Structure
Holdings as of 09/27/2026Detailed breakdown of ETF components
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BASILEA N | Healthcare | Biotechnology | 872,38 Mio. € | 2.71% | 16.33 | 14.29 | 51.40% | 5.00 | 3.28 | 11.90 | 21.60 | 4.63% | FY Cur +15.29% (2) Q Cur - (0) FY Next +2.70% (5) Q Next - (0) | FY Cur +37.29% (5) Q Cur - FY Next +6.35% (6) Q Next - | |
| 2 | Xeris Biopharma Holdings, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 1,71 Mrd. € | 2.70% | - | 28.32 | - | - | 5.70 | 41.53 | 36.43 | 2.75% | FY Cur +32.91% (6) Q Cur +36.71% (6) FY Next +23.75% (6) Q Next +9.18% (6) | FY Cur +0.00% (3) Q Cur +0.00% (3) FY Next +2319.56% (3) Q Next +287.48% (2) | |
| 3 | Halozyme Therapeutics, Inc. | Healthcare | Biotechnology | 11,19 Mrd. € | 2.70% | 32.29 | 10.39 | 1517.69% | 87.70 | 7.53 | 13.72 | 37.15 | 2.69% | FY Cur +33.93% (8) Q Cur +38.31% (6) FY Next +10.74% (8) Q Next +10.76% (6) | FY Cur +109.98% (6) Q Cur +35.12% (6) FY Next +22.02% (5) Q Next +12.69% (6) | |
| 4 | Ligand Pharmaceuticals Incorpor | Healthcare | Biotechnology | 5,37 Mrd. € | 2.69% | 31.80 | 25.26 | 116.94% | 6.21 | 20.71 | 42.51 | 43.05 | 2.32% | FY Cur +8.04% (11) Q Cur -32.44% (11) FY Next +31.71% (10) Q Next +23.77% (11) | FY Cur +14.46% (10) Q Cur -25.29% (10) FY Next +28.42% (10) Q Next +29.56% (10) | |
| 5 | Biogen Inc. | Healthcare | Drug Manufacturers - General | 29,76 Mrd. € | 2.65% | 40.09 | 13.65 | 44.33% | 1.77 | 3.33 | 11.71 | 26.32 | 3.80% | FY Cur +5.66% (32) Q Cur +4.00% (26) FY Next +2.04% (32) Q Next -1.22% (25) | FY Cur -17.96% (33) Q Cur -57.93% (26) FY Next +31.94% (33) Q Next +61.72% (26) | |
| 6 | EISAI CO LTD | Healthcare | Drug Manufacturers - Specialty & Generic | 7,33 Mrd. € | 2.64% | 33.86 | - | 29.08% | 1.43 | 1.52 | 13.36 | - | -2.12% | FY Cur +6.39% (14) Q Cur +12.05% (6) FY Next +6.38% (13) Q Next +8.51% (6) | FY Cur +47.59% (14) Q Cur +64.37% (3) FY Next +19.21% (14) Q Next +21.88% (3) | |
| 7 | Genmab A/S | Healthcare | Biotechnology | 20,1 Mrd. € | 2.63% | 30.16 | 22.15 | 88.52% | 3.69 | 36.39 | 104.88 | 172.68 | 0.58% | FY Cur +25.99% (19) Q Cur +20.30% (11) FY Next +16.94% (21) Q Next +5.32% (11) | FY Cur -27.32% (10) Q Cur -45.92% (3) FY Next +35.70% (11) Q Next -13.48% (3) | |
| 8 | ASTRAZENECA PLC ORD SHS $0.25 | Healthcare | Drug Manufacturers - General | 219,81 Mrd. € | 2.61% | 24.04 | 1051.81 | 64.22% | 494.17 | 3.03 | 10.46 | 36.34 | 2.75% | FY Cur +7.52% (27) Q Cur +5.54% (11) FY Next +6.16% (27) Q Next +4.09% (10) | FY Cur +11.80% (25) Q Cur +8.88% (9) FY Next +11.39% (25) Q Next -8.41% (9) | |
| 9 | BeOne Medicines Ltd. | Healthcare | Biotechnology | 35,99 Mrd. € | 2.60% | 63.41 | 34.58 | 39.61% | 7.74 | 6.58 | 34.30 | 45.88 | 2.18% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | FY Cur +202.03% (17) Q Cur +72.26% (12) FY Next +34.16% (17) Q Next -17.26% (12) | |
| 10 | RECORDATI ORD | Healthcare | Drug Manufacturers - General | 11,02 Mrd. € | 2.58% | 22.27 | 14.09 | 108.59% | 5.09 | 4.07 | 12.60 | 20.38 | 4.91% | FY Cur +6.63% (6) Q Cur +6.72% (1) FY Next +8.45% (5) Q Next +1.48% (1) | FY Cur +16.31% (4) Q Cur - FY Next +52.48% (4) Q Next - | |
| 11 | NIPPON SHINYAKU CO | Healthcare | Drug Manufacturers - Specialty & Generic | 1,28 Mrd. € | 2.57% | 7.64 | - | 0.86% | 0.77 | 1.26 | 3.74 | 11.51 | 8.69% | FY Cur +16.44% (8) Q Cur +0.64% (3) FY Next -12.25% (8) Q Next +22.91% (3) | FY Cur -11.02% (8) Q Cur -52.07% (2) FY Next -52.02% (8) Q Next +125.37% (2) | |
| 12 | Agios Pharmaceuticals, Inc. | Healthcare | Biotechnology | 1,69 Mrd. € | 2.56% | - | -7.91 | 3.04% | 1.85 | 19.31 | -2.91 | - | -14.46% | FY Cur +229.47% (10) Q Cur +302.96% (10) FY Next +94.99% (10) Q Next +16.72% (10) | FY Cur +19.72% (8) Q Cur +31.32% (8) FY Next +34.56% (10) Q Next +8.08% (10) | |
| 13 | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 562,31 Mrd. € | 2.54% | 29.71 | 21.26 | 57.71% | 7.41 | 6.43 | 18.54 | 37.31 | 2.68% | FY Cur +7.66% (12) Q Cur +5.84% (10) FY Next +7.04% (11) Q Next +4.27% (9) | FY Cur +2.70% (12) Q Cur -10.55% (11) FY Next +10.97% (11) Q Next +17.44% (10) | |
| 14 | Rigel Pharmaceuticals, Inc. | Healthcare | Biotechnology | 810,46 Mio. € | 2.54% | 2.91 | 9.94 | 9.39% | 2.15 | 3.28 | 9.53 | - | -3.50% | FY Cur +3.89% (5) Q Cur +15.31% (5) FY Next +21.95% (5) Q Next +10.02% (5) | FY Cur -44.90% (4) Q Cur -34.00% (4) FY Next +39.42% (4) Q Next +7.85% (4) | |
| 15 | Incyte Corporation | Healthcare | Biotechnology | 20,4 Mrd. € | 2.53% | 14.37 | 12.91 | 0.60% | 3.57 | 3.93 | 9.45 | 19.36 | 5.16% | FY Cur +15.49% (23) Q Cur +7.95% (20) FY Next +5.35% (23) Q Next +3.42% (19) | FY Cur -52.32% (19) Q Cur -262.56% (16) FY Next +169.37% (21) Q Next +152.33% (17) | |
| 16 | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 21,02 Mrd. € | 2.51% | 19.67 | 16.25 | - | 3.66 | 7.47 | 13.49 | 42.28 | 2.37% | FY Cur -0.74% (14) Q Cur -1.87% (13) FY Next +12.09% (14) Q Next +2.94% (13) | FY Cur -6.10% (14) Q Cur -13.24% (14) FY Next +15.44% (14) Q Next +10.83% (14) | |
| 17 | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 115,31 Mrd. € | 2.49% | 29.71 | 25.23 | 9.77% | 6.38 | 10.26 | 23.86 | 49.17 | 2.03% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | FY Cur -11.12% (16) Q Cur -115.38% (13) FY Next +23.62% (16) Q Next +721.48% (14) | |
| 18 | Jazz Pharmaceuticals plc | Healthcare | Biotechnology | 12,65 Mrd. € | 2.48% | 14.97 | 8.46 | 91.83% | 2.95 | 3.08 | 8.64 | 9.92 | 10.08% | FY Cur +10.61% (21) Q Cur +6.94% (18) FY Next +5.76% (21) Q Next +2.65% (18) | FY Cur +158.32% (19) Q Cur -61.86% (19) FY Next +19.25% (19) Q Next +109.81% (19) | |
| 19 | CHUGAI PHARMACEUTICAL CO | Healthcare | Drug Manufacturers - General | 55,86 Mrd. € | 2.47% | 20.99 | - | - | 4.88 | 7.38 | 13.19 | 29.81 | 3.35% | FY Cur +10.92% (14) Q Cur +4.53% (6) FY Next +10.15% (14) Q Next +5.46% (6) | FY Cur +16.14% (15) Q Cur +17.95% (3) FY Next +14.79% (15) Q Next +5.71% (3) | |
| 20 | Arbutus Biopharma Corporation | Healthcare | Biotechnology | 577,29 Mio. € | 2.44% | 5.34 | - | 1.40% | 3.22 | 3.56 | 5.00 | - | -12.40% | FY Cur +39.14% (1) Q Cur +87.37% (1) FY Next -97.75% (1) Q Next +0.00% (1) | FY Cur +540.38% (1) Q Cur +50.01% (1) FY Next -110.81% (1) Q Next +0.00% (1) | |
| 21 | INNOCARE | Healthcare | Biotechnology | 2,56 Mrd. € | 2.43% | 20.87 | 70.72 | 29.05% | 2.49 | 8.09 | 21.45 | 215.39 | 0.46% | FY Cur +3.78% (6) Q Cur +80.05% (1) FY Next +18.95% (7) Q Next +11.79% (1) | FY Cur -39.15% (1) Q Cur - FY Next -25.00% (1) Q Next - | |
| 22 | Alnylam Pharmaceuticals, Inc. | Healthcare | Biotechnology | 27,79 Mrd. € | 2.41% | 37.83 | 18.73 | 220.62% | 22.98 | 6.48 | 28.19 | 114.66 | 0.87% | FY Cur +47.50% (26) Q Cur +14.73% (20) FY Next +26.78% (26) Q Next +9.32% (20) | FY Cur +73.90% (14) Q Cur -21.24% (14) FY Next +40.62% (14) Q Next +19.29% (14) | |
| 23 | Travere Therapeutics, Inc. | Healthcare | Biotechnology | 4,33 Mrd. € | 2.40% | - | 9.24 | 2515.72% | 200.48 | 8.20 | 219.66 | - | -0.38% | FY Cur +47.65% (14) Q Cur +18.69% (14) FY Next +49.39% (14) Q Next +18.62% (14) | FY Cur +86.16% (8) Q Cur -16.97% (8) FY Next +232.85% (8) Q Next +125.35% (8) | |
| 24 | KYOWA KIRIN CO LTD | Healthcare | Drug Manufacturers - Specialty & Generic | 6,56 Mrd. € | 2.38% | 14.22 | - | - | 1.27 | 2.20 | 6.50 | 37.66 | 2.66% | FY Cur +0.14% (11) Q Cur +3.99% (5) FY Next +1.85% (11) Q Next +16.15% (5) | FY Cur +22.34% (11) Q Cur +22.22% (4) FY Next +16.08% (11) Q Next +40.15% (4) | |
| 25 | Swedish Orphan Biovitrum AB | Healthcare | Drug Manufacturers - Specialty & Generic | 13,24 Mrd. € | 2.38% | 111.56 | 18.84 | 41.61% | 3.52 | 4.87 | 13.15 | 43.65 | 2.29% | FY Cur +17.12% (10) Q Cur +14.55% (5) FY Next +12.26% (10) Q Next +2.48% (4) | FY Cur +15.23% (9) Q Cur -1.60% (3) FY Next +17.55% (9) Q Next -9.46% (2) |
Results: 41
Weight 2.71%
Market Cap €872.38M
P/E 16.3
Fwd P/E 14.3
Weight 2.7%
Market Cap €1.71B
P/E -
Fwd P/E 28.3
Weight 2.7%
Market Cap €11.19B
P/E 32.3
Fwd P/E 10.4
Weight 2.69%
Market Cap €5.37B
P/E 31.8
Fwd P/E 25.3
Weight 2.65%
Market Cap €29.76B
P/E 40.1
Fwd P/E 13.6
Weight 2.63%
Market Cap €20.1B
P/E 30.2
Fwd P/E 22.1
Weight 2.61%
Market Cap €219.81B
P/E 24.0
Fwd P/E 1051.8
Weight 2.6%
Market Cap €35.99B
P/E 63.4
Fwd P/E 34.6
Weight 2.58%
Market Cap €11.02B
P/E 22.3
Fwd P/E 14.1
Weight 2.57%
Market Cap €1.28B
P/E 7.6
Fwd P/E -
Weight 2.56%
Market Cap €1.69B
P/E -
Fwd P/E -7.9
Weight 2.54%
Market Cap €562.31B
P/E 29.7
Fwd P/E 21.3
Weight 2.54%
Market Cap €810.46M
P/E 2.9
Fwd P/E 9.9
Weight 2.53%
Market Cap €20.4B
P/E 14.4
Fwd P/E 12.9
Weight 2.51%
Market Cap €21.02B
P/E 19.7
Fwd P/E 16.3
Weight 2.49%
Market Cap €115.31B
P/E 29.7
Fwd P/E 25.2
Weight 2.48%
Market Cap €12.65B
P/E 15.0
Fwd P/E 8.5
Weight 2.47%
Market Cap €55.86B
P/E 21.0
Fwd P/E -
Weight 2.44%
Market Cap €577.29M
P/E 5.3
Fwd P/E -
Weight 2.43%
Market Cap €2.56B
P/E 20.9
Fwd P/E 70.7
Weight 2.41%
Market Cap €27.79B
P/E 37.8
Fwd P/E 18.7
Weight 2.4%
Market Cap €4.33B
P/E -
Fwd P/E 9.2
Weight 2.38%
Market Cap €6.56B
P/E 14.2
Fwd P/E -
Weight 2.38%
Market Cap €13.24B
P/E 111.6
Fwd P/E 18.8
Results 1 - 25 of 41
Per page:
Page 1 / 2